Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Trillium Therapeutics Inc.
T.TRIL
Healthcare
Biotechnology
Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:TRIL)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Next
(19)
•••
MJ MadeMeRich
X
View Profile
View Bullboard History
Comment by
MJ MadeMeRich
on Mar 08, 2019 5:25pm
RE:under a buck not for much longer
What's the news? Are we talking 1CAD or USD?
(82)
•••
ROUGETRADER719
X
View Profile
View Bullboard History
Post by
ROUGETRADER719
on Mar 08, 2019 10:11am
under a buck not for much longer
Get in before the crowd news will cause squeeze imo
QMET has 11 claims and 633 hectares Property in Ville-Marie, Quebec Hydrogen Camp
posted Nov 25, 2024 9:00am by
Q Precious & Battery Metals Corp.
-
|
The Company is pleased to discover that their Lorrain claims are now within the new and exciting exploration for hydrogen in the Ville-Marie, Lorrainville and Béarn region of Quebec. The region has undergone a claim staking rush following the ...read more
(19)
•••
MJ MadeMeRich
X
View Profile
View Bullboard History
Comment by
MJ MadeMeRich
on Mar 05, 2019 12:10am
RE:RE:Just bought In
$50? This year? You really must be dreaming. If it can hit $5 by the end of the year, count your blessings, nevermind $50 lol. Unless, and this is a big unless.... they have a big development with
...more
(8)
•••
harrison99
X
View Profile
View Bullboard History
Comment by
harrison99
on Mar 04, 2019 9:56pm
RE:Just bought In
Yes, a long here, since 2010...still full of hope...for the drug development and the stock price. At these prices, I was able to double down. And the news of all these institutional buyers can only
...more
(19)
•••
MJ MadeMeRich
X
View Profile
View Bullboard History
Post by
MJ MadeMeRich
on Feb 22, 2019 12:33pm
Just bought In
Just saw this massive collapse in share price. Looks like alot of pain for longs.... But looks like a great opportunity for new investors. With the share offering announced today, the price target
...more
(240)
•••
HuntNGather
X
View Profile
View Bullboard History
Post by
HuntNGather
on Jan 02, 2019 2:43pm
Happy New Year Everyone
It has been a rough ride with TRIL this past year + . This year may be very different because of the amazing early results that are being released and the several significant steps forward that we
...more
(0)
•••
PoorOpinion
X
View Profile
View Bullboard History
Post by
PoorOpinion
on Jun 21, 2018 12:12pm
Anybody see the "at-the-market" issurance
means that some significant news is in the pipeline? https://en.m.wikipedia.org/wiki/At-the-market_offering It's curious that this comes quickly on the heels of them clearing up the licencing
...more
(0)
•••
Pitvanpout99
X
View Profile
View Bullboard History
Post by
Pitvanpout99
on Apr 12, 2018 8:36am
The meeting will be held April 14-18 in Chicago
TRILLIUM THERAPEUTICS TO REPORT PRECLINICAL DATA ON TTI-621 AND TTI-622 AT THE AACR ANNUAL MEETING 2018
(240)
•••
HuntNGather
X
View Profile
View Bullboard History
Comment by
HuntNGather
on Mar 20, 2018 11:28am
RE:Orphan Drug Designation
Oh Erudite... I am with you on that. This is apparently very good news and a solid shot in the arm in support of what the TRIL people are doing. Safe, Effective... all good words. I too hoped
...more
(0)
•••
Erudite
X
View Profile
View Bullboard History
Post by
Erudite
on Mar 20, 2018 8:42am
Orphan Drug Designation
Wow! This is great news, finally! Let's see how the market reacts today. All fingers and toes crossed. GLTA Erudite
(8)
•••
robins1
X
View Profile
View Bullboard History
Comment by
robins1
on Dec 18, 2017 4:51pm
RE:RE:new here , but been watching
I bought some options for next Aug . I dont know how low it will go , or when it will turn . but when the company issues good news , millions of shorts will have to start covering .
(4)
•••
thesheet
X
View Profile
View Bullboard History
Comment by
thesheet
on Dec 18, 2017 4:45pm
RE:new here , but been watching
i sold, but will buy back "soon".
(8)
•••
robins1
X
View Profile
View Bullboard History
Post by
robins1
on Dec 18, 2017 4:40pm
new here , but been watching
I had to sign up to say some things : 52% of Trll is held by corporate . 20% is held by Matrix invest corp : 20 mil shares at approx 8.50 U.S. do you really think they are going to stand by and watch
...more
(4)
•••
thesheet
X
View Profile
View Bullboard History
Comment by
thesheet
on Dec 17, 2017 3:59pm
RE:$150M
that's a ship-tonne. back to 5$ for trading opp?
(0)
•••
SOX2STOX
X
View Profile
View Bullboard History
Post by
SOX2STOX
on Dec 16, 2017 8:53pm
$150M
https://t.co/37wdUyK9TH https://trilliumtherapeutics.com/investors/sec-filings/sec-filings-details/default.aspx?FilingId=12432059
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income